Clinical Trial: Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: A Multi-center, Single-blind, Parallel-design, Randomized, Placebo-controlled, Dose-ranging Study to Evaluate Oral Recombinant Microbial Lipase Efficacy in Patients With Pancreat

Brief Summary: This study is to estimate the efficacy of a number of doses in patients with pancreatic insufficiency

Detailed Summary:
Sponsor: Solvay Pharmaceuticals

Current Primary Outcome: CFA (Coefficient of Fat Absorption) [ Time Frame: from baseline to end of 7 days treatment ]

Original Primary Outcome: Same as current

Current Secondary Outcome: CNA, stool fat, stool weight, nutritional parameters, clinical symptomatology [ Time Frame: from baseline to end of 7 days treatment ]

Original Secondary Outcome: Same as current

Information By: Solvay Pharmaceuticals

Dates:
Date Received: February 22, 2008
Date Started: February 2008
Date Completion:
Last Updated: August 4, 2009
Last Verified: August 2009